206357-82-6

Usage

Uses

Used in Pharmaceutical Research:
2-(3-Bromobenzoyl)pyridine is used as a building block for the development of new drugs, leveraging its potential biological and pharmacological properties to contribute to the creation of innovative therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, 2-(3-Bromobenzoyl)pyridine serves as an intermediate in the synthesis of other chemical compounds, playing a crucial role in the production of various organic molecules.

InChI:InChI=1/C12H8BrNO/c13-10-5-3-4-9(8-10)12(15)11-6-1-2-7-14-11/h1-8H

Upstream product

• 109-04-6 2-bromo-pyridine 
• 15930-59-3 3-bromo-N,N-dimethylbenzamide 
• 1711-09-7 3-bromobenzoyl chloride 
• 856957-26-1 1-bromo-3-[1-hydroxy-1-(2-pyridyl)methyl]benzene 
• 3132-99-8 m-bromobenzoic aldehyde 
• 98-98-6 2-Picolinic acid 

Downstream Products

• 1613186-49-4 2-[(3-bromophenyl)(hydrazono)methyl]pyridine 
• 1613186-54-1 3-(3-bromophenyl)-[1,2,3]triazolo[1,5-a]pyridine 
• 1372806-02-4 C₁₄H₁₀BrN₃O₂ 
• 887911-86-6 C₂₁H₁₇ClN₄O 
• 1372806-38-6 C₁₅H₁₃BrN₄O 
• 1372806-32-0 C₁₅H₁₂BrN₃OS 
• 1372806-17-1 C₁₅H₁₂BrN₃O₂ 

Relevant academic research and scientific papers

Organic electroluminescent materials and devices

Novel phosphorescent platinum complexes containing tetradentate ligands are provided. The disclosed compounds have three 6-membered metallocycle units in each tertadentate ligand. The disclosed compounds have desirable electronic properties that make them useful when incorporated into a variety of OLED devices.

Facile one-pot synthesis of [1,2,3]triazolo[1,5-a]pyridines from 2-acylpyridines by copper(II)-catalyzed oxidative N-N bond formation

An efficient and simple method for the synthesis of various [1,2,3]triazolo[1,5-a]pyridines has been established. The method involves a copper(II)-catalyzed oxidative N-N bond formation that uses atmospheric oxygen as the terminal oxidant following hydrazonation in one pot. The use of ethyl acetate as the solvent dramatically promotes the oxidative N-N bond-formation reaction and enables the application of oxidative cyclization in the efficient one-pot reaction. A mechanism for the reaction was proposed on the basis of the results of a spectroscopic study. In the same pot: [1,2,3]Triazolo[1,5-a] pyridines are synthesized from the corresponding 2-acylpyridines by a one-pot method, consisting of hydrazonation followed by oxidative cyclization through copper(II)-catalyzed N-N bond formation (see scheme).

1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof

Certain 1-(aromatic- or heteroaromatic-substituted-3-(heteroaromatic substituted)-1,3-propanediones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.